Literature DB >> 15123870

Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.

Mukaddes Kalyoncu1, Gulseren Cimsit, Murat Cakir, Aysenur Okten.   

Abstract

We report a case of toxic epidermal necrolysis who was successfully treated with intravenous immunoglobin and granulocyte colony-stimulating factor. He had poor prognostic factors such as extensive epidermal loss, neutropenia, acute respiratory distress syndrome and candida sepsis, but nonetheless made a complete recovery.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15123870

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  3 in total

1.  Intravenous immunoglobulin in the treatment of vancomycin-induced toxic epidermal necrolysis.

Authors:  Mohamed A El-Naggari; Hashim Javad; Alexander P Chacko; Anas A Abdelmogheth
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

2.  A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata.

Authors:  Sudip Das; Aloke Kumar Roy; Indranil Biswas
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

3.  Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Authors:  Rajesh Kumar; Anupam Das; Sudip Das
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.